Enlivex Therapeutics (ENLV) Stock Chart & Stock Price History $0.89 -0.03 (-3.04%) As of 04/11/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enlivex Therapeutics Stock Price Performance 5 Day Performance-1.37%1 Month Performance-17.66%3 Month Performance-21.96%6 Month Performance-38.54%Year-To-Date Performance-23.29%1 Year Performance-43.20% Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ENLV Stock Chart for Sunday, April, 13, 2025 ENLV Chart by TradingViewRemove Ads Enlivex Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/11/2025$0.91$0.90-1.37%$0.92$0.8636,661 shs$19.21 million04/10/2025$0.92$0.91-1.09%$0.92$0.8722,291 shs$19.48 million04/09/2025$0.91$0.92+1.10%$0.92$0.86112,217 shs$19.69 million04/09/2025$0.91$0.92+1.10%$0.92$0.86112,217 shs$19.69 million04/08/2025$0.89$0.91+2.25%$0.93$0.8772,415 shs$19.48 million04/08/2025$0.89$0.91+2.25%$0.93$0.8772,415 shs$19.48 million04/07/2025$0.89$0.89+0.23%$0.92$0.8681,549 shs$19.05 million04/04/2025$0.95$0.89-6.17%$0.94$0.85104,012 shs$19.01 million04/03/2025$1.01$0.95-6.30%$1.01$0.9559,429 shs$20.26 million04/02/2025$0.95$1.01+6.32%$1.02$0.92110,400 shs$21.62 million Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/01/2025$0.97$0.95-2.08%$1.03$0.9288,196 shs$20.34 million03/31/2025$1.02$0.97-4.88%$1.04$0.97106,285 shs$20.77 million03/28/2025$1.01$1.02+0.99%$1.04$1.0049,313 shs$21.83 million03/27/2025$1.05$1.01-3.81%$1.05$1.0123,369 shs$21.62 million03/26/2025$1.09$1.05-3.67%$1.11$1.01106,880 shs$22.48 million03/25/2025$1.02$1.09+6.86%$1.11$1.0445,820 shs$23.33 million03/24/2025$1.05$1.02-2.39%$1.13$1.02167,805 shs$21.83 million03/21/2025$1.09$1.05-4.13%$1.13$1.0176,037 shs$22.37 million03/20/2025$1.12$1.09-2.68%$1.13$1.05159,811 shs$23.33 million03/19/2025$1.14$1.12-1.75%$1.18$1.0895,944 shs$23.98 million03/18/2025$1.15$1.14-0.87%$1.24$1.12151,563 shs$24.40 million03/17/2025$1.22$1.15-5.74%$1.22$1.10177,406 shs$24.62 million03/14/2025$1.09$1.22+11.93%$1.29$1.12236,236 shs$26.12 million03/13/2025$1.20$1.09-9.17%$1.23$1.07120,792 shs$23.33 million03/12/2025$1.16$1.20+3.45%$1.24$1.1678,683 shs$25.69 million Related Companies PLRX Stock Chart CLYM Stock Chart VTYX Stock Chart ACOG Stock Chart MGNX Stock Chart CRDL Stock Chart CRVO Stock Chart TCRX Stock Chart BMEA Stock Chart GALT Stock Chart Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENLV) was last updated on 4/13/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enlivex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENLV Stock Free ENLV Stock Alerts